Refine by
Biomarker Detection Articles & Analysis
28 news found
Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...
This study focused on the performance of Seravue and the LC-SPIK biomarker in detecting hepatocellular carcinoma (HCC) in a pool of nonalcoholic fatty liver disease (NAFLD) related cirrhosis patients. Here, LC-SPIK had an AUC of 0.841 and significantly outperformed AFP, the most common biomarker used for HCC detection today. ...
The study found that sex differences can be observed via digital biomarkers, which has the potential to impact diagnosis and treatment of AD. “Our research shows how digital biomarkers can detect sex-based differences which are often overlooked when using standardized cognitive neuropsychological assessment,” said Antonella ...
The study found that sex differences can be observed via digital biomarkers, which has the potential to impact diagnosis and treatment of AD. “Our research shows how digital biomarkers can detect sex-based differences which are often overlooked when using standardized cognitive neuropsychological assessment,” said Antonella ...
” Highlights from the first quarter and recent weeks include: The American College of Gastroenterology (“ACG”) updated its clinical guideline for the diagnosis and management of esophageal precancer, endorsing, for the first time, nonendoscopic biomarker screening to detect precancer and prevent highly lethal esophageal cancer, providing ...
Biomarker detection can provide insight into the mechanism of action or resistance of new drugs in disease models. Creative Proteomics can provide detection services for cytokines and biomarkers for the majority of pharmaceutical R&D personnel. Its Cytokine division has complete infrastructure and advanced equipment, and ...
Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF). ...
CAC is a recognized vital biomarker for detection of cardiovascular disease. Nanox.AI believes that early detection and subsequent treatment of cardiovascular disease has the potential to significantly decrease the morbidity and mortality of this highly prevalent condition. ...
According to X-ZELL’s Head of Engineering & Product Development, Sven Strache, the technology is crucial to the routine discovery of next-generation biomarkers for early cancer detection and has set a new standard for white blood cell depletion from whole blood. ...
“In 2017 we developed a platform technology capable of detecting previously undetectable cells in a routine lab,” Dr Bhakdi commented. ...
The results showed that all three different first-void urine collection volumes with Urine Conservation Medium (UCM) allow for biomarker detection. Human Papillomavirus (HPV) can be detected in first-void urine Methods to optimize first-void urine collection Study summary: Impact of different urine volumes on detection of ...
Methylation patterns on the promoter regions of tumor suppressor genes involved in cervical cancer development have demonstrated to be sensitive biomarkers to detect cervical cancer and severe precursor stadia (CIN3+). ...
Analysis of other potential blood-based biomarkers using CAMP study samples is ongoing. Validation of additional metabotypes of ASD is expected to result in the ability to detect a still higher percentage of children at risk of ASD using this approach. ...
The Oncomine Precision Assay, which is designed to detect key biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue and liquid biopsy specimens, contains more than 50 cancer-related biomarkers and has the lowest sample input requirements on the market for detection of both DNA and RNA variants. ...
Co-founders and biomedical engineers Corey Centen and Sarah Smith founded Bodyport to develop a novel biomarker platform that could detect early signs of cardiovascular disease, incorporating proprietary sensor technology into a bathroom scale form factor. Rather than relying on wearables, the Bodyport Scale is designed to detect cardiac signals ...
Under the terms of the agreement, the companies will collaboratively validate the biomarkers for a test that will be based on Thermo Fisher's Oncomine Precision Assay and used to identify variant-positive patients. ...
Digital biomarker awards support technology solutions for early detection of Alzheimer’s and related dementias Data platform enables researchers using digital tools to share their findings for benchmarking, analysis and use across research projects ADDF’s Diagnostics Accelerator has $50 million in commitments from leading philanthropists Leonard ...
The consensus is arising in the field that to treat AD effectively, early detection is a must. Because current biomarker analysis procedures are long and cumbersome, there is a critical need for a novel minimally invasive and cost-effective diagnostic assay to facilitate routine screening and early detection of AD. ...
DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today a $492,000 award in support of the project entitled "Circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration." The award will accelerate the development of DiamiR's targeted diagnostic technology for detection and ...
ByDiamiR
Jean-Claude Tardif’s research group from the Montreal Heart Institute, have partnered with the aim to develop a new biomarker for atherosclerosis diagnosis. Atherosclerosis is a disease in which plaque build-up results in thickening and hardening of the walls of the arteries. ...